QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)

Healthcare Stocks List

Compare healthcare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. JNJ, MRK, PFE, NVS, UNH, ABT, CVS, TDOC, CRSP, LLY).

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$110.49
+0.2%
$108.91
$101.24
$142.60
$193.49B0.715.58 million shs3.26 million shs
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$77.46
-1.8%
$72.19
$42.51
$139.61
$6.00B1.931.71 million shs1.44 million shs
CVS Health Co. stock logo
CVS
CVS Health
$104.25
+0.2%
$94.73
$81.78
$111.25
$136.86B0.755.83 million shs3.97 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$167.14
-2.1%
$174.67
$155.72
$186.69
$439.44B0.597.47 million shs9.23 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and
$301.17
-1.1%
$315.34
$220.20
$335.33
$286.16B0.352.91 million shs2.19 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$88.93
-0.3%
$90.09
$70.89
$95.72
$225.28B0.3211.72 million shs7.31 million shs
Novartis AG stock logo
NVS
Novartis
$85.58
-2.1%
$84.81
$79.09
$95.17
$189.35B0.512.45 million shs2.72 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$48.29
-3.3%
$50.89
$40.94
$61.71
$270.95B0.6727.21 million shs43.82 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$37.99
+0.5%
$36.70
$27.38
$156.82
$6.12B0.826.29 million shs6.96 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$532.86
-0.9%
$508.77
$383.12
$553.29
$498.43B0.763.31 million shs3.00 million shs

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+2.19%+0.60%+1.27%+2.13%-10.13%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
+4.98%+0.37%+7.00%+69.47%-41.65%
CVS Health Co. stock logo
CVS
CVS Health
+0.35%+2.63%+9.86%+5.90%+25.00%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.29%-2.25%-4.31%-4.05%-1.78%
Eli Lilly and Company stock logo
LLY
Eli Lilly and
+0.52%-2.94%-7.99%+4.39%+13.05%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-0.37%+1.79%-5.42%-1.81%+18.62%
Novartis AG stock logo
NVS
Novartis
+0.32%+3.03%+3.48%+2.40%-5.25%
Pfizer Inc. stock logo
PFE
Pfizer
+0.34%+0.18%-5.56%-0.87%+3.65%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
+6.72%-1.84%-2.93%+23.13%-74.26%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
+0.09%-0.54%+4.02%+12.31%+30.58%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
3.05 of 5 Stars
3.44.04.24.42.82.51.3
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2.65 of 5 Stars
4.32.00.00.02.82.51.9
CVS Health Co. stock logo
CVS
CVS Health
2.67 of 5 Stars
2.43.02.53.53.02.52.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.95 of 5 Stars
2.35.04.23.93.42.51.9
Eli Lilly and Company stock logo
LLY
Eli Lilly and
2.76 of 5 Stars
1.45.03.34.02.22.53.1
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.69 of 5 Stars
2.35.04.24.22.41.71.3
Novartis AG stock logo
NVS
Novartis
1.67 of 5 Stars
1.03.02.50.01.60.02.5
Pfizer Inc. stock logo
PFE
Pfizer
2.95 of 5 Stars
2.35.04.24.31.72.52.5
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.59 of 5 Stars
4.14.00.00.02.12.51.3
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
3.19 of 5 Stars
2.55.04.24.03.03.32.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.71
Moderate Buy$132.4619.88% Upside
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2.56
Moderate Buy$112.3345.02% Upside
CVS Health Co. stock logo
CVS
CVS Health
2.80
Moderate Buy$117.4712.68% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.56
Moderate Buy$189.8913.61% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and
2.83
Moderate Buy$317.005.26% Upside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.61
Moderate Buy$97.449.57% Upside
Novartis AG stock logo
NVS
Novartis
2.00
Hold$87.332.05% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.50
Moderate Buy$57.5019.07% Upside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.15
Hold$67.9778.90% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.90
Moderate Buy$585.009.78% Upside

Current Analyst Ratings

Latest Technology Stocks Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/10/2022
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$550.00 ➝ $600.00
8/9/2022
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$55.00 ➝ $69.00
8/9/2022
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy$164.00 ➝ $154.00
8/9/2022
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform$85.00 ➝ $79.00
8/9/2022
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral$74.00 ➝ $90.00
8/9/2022
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$99.00 ➝ $88.00
8/9/2022
Pfizer Inc. stock logo
PFE
Pfizer
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$52.00
8/8/2022
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform$112.00 ➝ $107.00
8/8/2022
CVS Health Co. stock logo
CVS
CVS Health
Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform$113.00 ➝ $117.00
8/4/2022
CVS Health Co. stock logo
CVS
CVS Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$118.00 ➝ $127.00
8/4/2022
CVS Health Co. stock logo
CVS
CVS Health
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$113.00 ➝ $120.00
(Data available from 8/11/2019 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$43.08B4.49$7.47 per share14.79$20.97 per share5.27
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$914.96M6.56$5.52 per share14.03$26.80 per share2.89
CVS Health Co. stock logo
CVS
CVS Health
$292.11B0.47$12.26 per share8.50$57.51 per share1.81
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$93.78B4.69$12.53 per share13.34$29.04 per share5.76
Eli Lilly and Company stock logo
LLY
Eli Lilly and
$28.32B10.11$9.34 per share32.26$9.11 per share33.06
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$48.70B4.63$7.27 per share12.23$17.10 per share5.20
Novartis AG stock logo
NVS
Novartis
$52.88B3.58$8.86 per share9.66$28.48 per share3.00
Pfizer Inc. stock logo
PFE
Pfizer
$81.29B3.33$5.26 per share9.18$13.80 per share3.50
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.03B3.01$0.48 per share79.61$37.75 per share1.01
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$287.60B1.73$22.42 per share23.77$81.47 per share6.54

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$7.07B$4.7923.0723.814.0018.78%29.38%14.14%10/19/2022 (Estimated)
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$377.66M-$8.23N/AN/AN/A-4,274.02%-27.40%-23.81%11/2/2022 (Estimated)
CVS Health Co. stock logo
CVS
CVS Health
$7.91B$6.1516.9511.371.582.65%15.19%4.89%11/2/2022 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$20.88B$6.8724.3315.923.2419.21%36.14%14.88%10/18/2022 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and
$5.58B$6.2748.0332.282.0719.58%85.58%15.79%10/25/2022 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$13.05B$6.5313.6212.371.2129.00%48.45%18.58%10/27/2022 (Estimated)
Novartis AG stock logo
NVS
Novartis
$24.02B$10.238.3712.812.4644.31%21.88%10.89%10/25/2022 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$21.98B$5.119.458.960.6128.92%44.38%19.24%11/1/2022 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$428.79M-$61.40N/AN/AN/A-441.94%-2.04%-1.77%10/26/2022 (Estimated)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$17.29B$19.1527.8321.561.665.95%25.45%8.73%10/13/2022 (Estimated)

Latest Healthcare Stocks Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/8/2022N/A
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
-$2.21-$2.40-$0.19N/A$2.20 million$0.20 million
8/4/2022Q2
Eli Lilly and Company stock logo
LLY
Eli Lilly and
$1.86$1.25-$0.61N/A$6.85 billion$6.49 billion      
8/3/2022Q2
CVS Health Co. stock logo
CVS
CVS Health
$2.16$2.40+$0.24N/A$76.38 billion$80.64 billion      
7/28/2022Q2 22
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$1.69$1.87+$0.18N/A$13.85 billion$14.59 billion    
7/28/2022Q2
Pfizer Inc. stock logo
PFE
Pfizer
$1.95$2.04+$0.09N/A$26.20 billion$27.74 billion    
7/20/2022Q2 2022
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.09$1.43+$0.34$1.72$10.37 billion$11.26 billion    
7/19/2022Q2 22
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.57$2.59+$0.02N/A$23.85 billion$24.02 billion    
7/18/2022N/A
Novartis AG stock logo
NVS
Novartis
$1.52$1.56+$0.04N/A$12.78 billion$12.78 billion    
7/15/2022Q2 2022
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$5.24$5.57+$0.33$5.80$79.68 billion$80.33 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.881.70%+16.20%39.25%50 Years
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
N/AN/AN/AN/AN/A
CVS Health Co. stock logo
CVS
CVS Health
$2.202.11%+19.35%35.77%1 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.522.70%+5.78%65.79%61 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and
$3.921.30%+14.81%62.52%8 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.763.10%+9.88%42.27%12 Years
Novartis AG stock logo
NVS
Novartis
$2.162.52%N/A21.11%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.603.31%+4.39%31.31%12 Years
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$6.601.24%+17.52%34.46%14 Years

Latest YECO, WXMN, GEVI, and MSMY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/26/2022
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Quarterly$0.693.03%9/14/20229/15/202210/7/2022
6/27/2022
Eli Lilly and Company stock logo
LLY
Eli Lilly and
quarterly$0.981.2%8/12/20228/15/20229/9/2022
7/18/2022
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Quarterly$1.132.63%8/22/20228/23/20229/6/2022
6/23/2022
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.403.22%7/28/20226/29/20229/6/2022
6/10/2022
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.471.7%7/14/20227/15/20228/15/2022
7/6/2022
CVS Health Co. stock logo
CVS
CVS Health
quarterly$0.552.37%7/21/20227/22/20228/1/2022
5/24/2022
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Quarterly$0.692.94%6/14/20226/15/20227/8/2022
6/9/2022
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$1.651.3%6/16/20226/20/20226/28/2022
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46
2.01
1.54
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
N/A
19.88
19.88
CVS Health Co. stock logo
CVS
CVS Health
0.67
0.91
0.65
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.37
1.42
1.17
Eli Lilly and Company stock logo
LLY
Eli Lilly and
1.70
1.10
0.85
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.75
1.40
1.14
Novartis AG stock logo
NVS
Novartis
0.35
1.38
1.13
Pfizer Inc. stock logo
PFE
Pfizer
0.43
1.39
1.13
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.25
3.38
3.22
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.60
0.77
0.77

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
113,0001.75 billion1.74 billionOptionable
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
47377.46 million69.17 millionOptionable
CVS Health Co. stock logo
CVS
CVS Health
300,0001.31 billion1.30 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
141,7002.63 billion2.62 billionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and
35,000950.18 million949.04 millionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
68,0002.53 billion2.53 billionOptionable
Novartis AG stock logo
NVS
Novartis
104,3232.21 billion2.21 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
79,0005.61 billion5.61 billionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,100161.18 million158.69 millionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
350,000935.38 million931.64 millionOptionable

Healthcare Stocks Headlines

SourceHeadline
UnitedHealthcare’s Surest Offers a New Approach to Health InsuranceUnitedHealthcare’s Surest Offers a New Approach to Health Insurance
finance.yahoo.com - August 11 at 6:16 PM
Ensign Group (ENSG) Stock Up 6% Since Q2 Earnings ReleaseEnsign Group (ENSG) Stock Up 6% Since Q2 Earnings Release
finance.yahoo.com - August 11 at 6:16 PM
UnitedHealthcare and Optum Donate $205,000 to Support Eastern Kentucky Communities Devastated by Recent FloodingUnitedHealthcare and Optum Donate $205,000 to Support Eastern Kentucky Communities Devastated by Recent Flooding
finance.yahoo.com - August 10 at 6:40 PM
The 2 Dow Stocks with Decade-Long Win Streaks on the Line (UNH)The 2 Dow Stocks with Decade-Long Win Streaks on the Line (UNH)
marketbeat.com - August 10 at 5:42 PM
UnitedHealthcare Donates $500,000 to Nonprofits in OklahomaUnitedHealthcare Donates $500,000 to Nonprofits in Oklahoma
mobilitytechzone.com - August 10 at 1:39 PM
UnitedHealthcare Donates $500,000 to Nonprofits in MississippiUnitedHealthcare Donates $500,000 to Nonprofits in Mississippi
tmcnet.com - August 10 at 1:39 PM
UnitedHealth Group (NYSE:UNH) Could Easily Take On More DebtUnitedHealth Group (NYSE:UNH) Could Easily Take On More Debt
nasdaq.com - August 10 at 1:39 PM
UnitedHealthcare Donates $1 Million to Nonprofits in WashingtonUnitedHealthcare Donates $1 Million to Nonprofits in Washington
finance.yahoo.com - August 10 at 1:39 PM
UnitedHealthcare Donates $1.5 Million to Nonprofits in CaliforniaUnitedHealthcare Donates $1.5 Million to Nonprofits in California
finance.yahoo.com - August 10 at 1:39 PM
UnitedHealthcare Donates $500,000 to Nonprofits in NevadaUnitedHealthcare Donates $500,000 to Nonprofits in Nevada
finance.yahoo.com - August 10 at 1:39 PM
Mizuho Increases UnitedHealth Group (NYSE:UNH) Price Target to $600.00Mizuho Increases UnitedHealth Group (NYSE:UNH) Price Target to $600.00
marketbeat.com - August 10 at 11:04 AM
Are Medtronic And Intuitive Surgical Poised For Big Growth?  (UNH)Are Medtronic And Intuitive Surgical Poised For Big Growth? (UNH)
marketbeat.com - August 9 at 10:27 AM
ClearBridge Investments: What Makes UnitedHealth Group Incorporated (UNH) Attractive?ClearBridge Investments: What Makes UnitedHealth Group Incorporated (UNH) Attractive?
insidermonkey.com - August 9 at 8:31 AM
UnitedHealth, Orlando Health have the most Central Florida jobs to start AugustUnitedHealth, Orlando Health have the most Central Florida jobs to start August
finance.yahoo.com - August 5 at 3:39 PM
Dow Jones Slides On Strong Jobs Report; Square Stock Dives On Earnings; Tesla Stock Split ApprovedDow Jones Slides On Strong Jobs Report; Square Stock Dives On Earnings; Tesla Stock Split Approved
finance.yahoo.com - August 5 at 10:39 AM
EXCLUSIVE UnitedHealth struggling to sell Brazilian unit Amil - sourcesEXCLUSIVE UnitedHealth struggling to sell Brazilian unit Amil - sources
reuters.com - August 4 at 7:38 PM
Unitedhealth Group UNH Investment AnalysisUnitedhealth Group UNH Investment Analysis
news.stocktradersdaily.com - August 4 at 7:38 PM
Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending StockHere is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock
nz.yahoo.com - August 4 at 2:37 PM
Dow Jones Falls After Jobless Data; Alibaba Jumps On EarningsDow Jones Falls After Jobless Data; Alibaba Jumps On Earnings
finance.yahoo.com - August 4 at 9:37 AM
UnitedHealth pauses plan to sell Brazilian insurer AmilUnitedHealth pauses plan to sell Brazilian insurer Amil
bizjournals.com - August 3 at 6:26 PM
EXCLUSIVE UnitedHealth struggling to sell Brazilian unit AmilEXCLUSIVE UnitedHealth struggling to sell Brazilian unit Amil
msn.com - August 3 at 1:25 PM
Dow Jones Futures Climb Ahead Of Key Economic Data; AMD Tumbles On Weak Sales OutlookDow Jones Futures Climb Ahead Of Key Economic Data; AMD Tumbles On Weak Sales Outlook
finance.yahoo.com - August 3 at 8:25 AM
Dow Jones Sells Off As Pelosi Heads To Taiwan; Uber Surges On Strong SalesDow Jones Sells Off As Pelosi Heads To Taiwan; Uber Surges On Strong Sales
finance.yahoo.com - August 2 at 9:58 AM
Stocks slide to start in August after best month since 2020Stocks slide to start in August after best month since 2020
marketbeat.com - August 2 at 2:53 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
CRISPR Therapeutics logo

CRISPR Therapeutics

NASDAQ:CRSP
CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.
CVS Health logo

CVS Health

NYSE:CVS
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Eli Lilly and logo

Eli Lilly and

NYSE:LLY
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Merck & Co., Inc. logo

Merck & Co., Inc.

NYSE:MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Novartis logo

Novartis

NYSE:NVS
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Teladoc Health logo

Teladoc Health

NYSE:TDOC
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
UnitedHealth Group logo

UnitedHealth Group

NYSE:UNH
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.